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a b s t r a c t 
Background: Diabetes mellitus (DM) is a major public health problem worldwide that was estimated to 
have affected the lives of 425 million people globally in 2017. The prevalence and mortality rates of DM 
have increased rapidly in low- and middle-income countries with an estimated 2.6 million cases of DM 
occurring in Ethiopia alone in 2015. 
Objective: Considering that Ethiopia is undergoing an epidemiological transition, it is increasingly im- 
portant to understand the significant influence DM has on Ethiopians annually. A systematic review and 
meta-analysis of the existing studies were conducted to better understand the factors that are associated 
with DM medication adherence across Ethiopia and to elucidate areas for further studies. 
Methods: Studies were retrieved through search engines in Cumulative Index to Nursing and Allied Health 
Literature, Embase, Medline, PubMed, Google Scholar, Web of Science, Science Direct, and Scopus. The 
Newcastle–Ottawa Scale for cross-sectional studies was used to assess the critical appraisal of the in- 
cluded studies. Random effects model was used to estimate the association between the level of med- 
ication adherence and the geographic location of a patient’s residence and presence of a glucometer at 
95% CI with its respective odds ratio. Meta-regression was also used to identify the potential source of 
heterogeneity. Beggs and Egger tests were performed to determine publication bias. Subgroup analyses, 
based on the study area, were also performed. 
Results: A total of 1046 articles were identified through searching, of which 19 articles representing 7756 
participants were included for the final analysis stage. Reported good medication adherence among pa- 
tients with diabetes in Ethiopia was 68.59% (95% CI, 62.00%–75.18%). Subgroup analysis was performed, 
and the pooled estimate of reported good medication adherence among these patients in regions outside 
Addis Ababa was 67.81% (95% CI, 59.96%–75.65%), whereas in Addis Ababa it was 70.37% (95% CI, 57.51%–
83.23%). Patients who used a glucometer at home had an odds ratio of 2.12 (95% CI, 1.42–3.16) and thus 
reported good adherence. We found no statistically significant association between the geographic loca- 
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a  ntroduction 
Diabetes mellitus (DM) is a major public health problem that
as estimated to have impacted 425 million people globally in
017. 1 According to the World Health Organization, “in 2016, an
stimated 1.6 million deaths were directly caused by diabetes.”2 
lthough world leaders have targeted DM as a noncommunica-
le disease of priority, the prevalence of diabetes has steadily in-
reased over the past few decades. 1–3 The global prevalence (age
tandardized) of diabetes specifically has nearly doubled since
980, increasing from 4.7% to 8.5% in the adult population in
014. 1 
The prevalence and mortality rates of DM are higher in low-
nd middle-income countries than those in high-income coun-
ries. 1 Sub-Saharan Africa has been particularly affected by this
rend. Within sub-Saharan Africa, an estimated 2.6 million cases
f DM occurred in Ethiopia alone in 2015. 2 
Ethiopia is currently undergoing a major epidemiological transi-
ion. 4 As described by other authors, 5 , 6 an epidemiological transi-
ion occurs when the disease burden of a population changes from
nfectious to noncommunicable. Epidemiological transitions have
een largely observed over the past centuries in high- and middle-
ncome countries. Thus, the adequacy of existing frameworks for
escribing the transitions now occurring in low-income countries
s being debated. In sub-Saharan Africa, among the largest barri-
rs preventing confidence in these models is the lack of data and
vidence-based written sources documenting the changes in epi-
emiology and demographic characteristics. 7 In Ethiopia, a com-
lete in-country vital registration system is lacking, leaving re-
earchers only the ability to estimate the mortality burden from
ommunicable and noncommunicable diseases. 4 Some work has
een performed to try to fill in data gaps, but their results may
ot be representative of all of Ethiopia. 8 , 9 Although past resources
nd policy have focused on reducing the influence of communi-
able diseases, it is only recently that noncommunicable diseases
ave been prioritized. 4 , 10 
The effort s that have been made to quantify the prevalence of
verweight and obese Ethiopians 11 , 12 have found that a significant
roportion of Ethiopians in certain regions are overweight, but still,
dditional studies are required to adequately understand the scope
f the problem. Obesity has been associated with the consump-
ion of a more Western-style diet high in processed and fatty foods
or wealthier Ethiopians. 12–14 The incidence rates of diagnosed di-
betes were also found to be 5 times higher in urban regions than
n rural regions. 15 
In summary, Ethiopia is facing a double disease burden from
ommon infectious and noncommunicable diseases, which include
M. Little work has been performed to map the epidemiology
nd management of DM in Ethiopia. This is problematic consider-
ng that complications associated with uncontrolled blood glucose
evel also disparately influence sub-Saharan Africa. 3 For example,
he prevalence of retinopathy, a common complication in DM pa-
ients, was 3% in Central Africa, 3.4% in Southern Africa, and 3.1% inDownloaded for Anonymous User (n/a) at University of Gronin
For personal use only. No other uses without permissiond a good level of reported medication adherence (odds ratio, 1.81; 95% CI,
ts with diabetes in these studies had a good level of reported DM med-
cometer was significantly associated with reported increased medication
t the need for interventions to improve diabetes medication adherence. 
© 2020 The Author(s). Published by Elsevier Inc.
This is an open access article under the CC BY-NC-ND license.
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est Africa, all of which exceed the global rate of diabetes-related
etinopathy at 2.6%. 1 , 16 , 17 
In addition to the influence on morbidity and mortality, DM
lso places a financial burden on countries with high DM preva-
ence. In total, the global health care expenditure on people with
iabetes was estimated to be $850 billion in 2017. 1 , 18 
Little is known about managing DM in Ethiopia; however, a sys-
ematic review conducted by Nigatu 18 found that access to ser-
ices, provision of care, glycemic control, and diabetes education
ere crucial components of well-managed DM. Previous studies
ave also shown that patients with chronic noncommunicable dis-
ases such as diabetes have difficulty adhering to their recom-
ended treatment regimens, resulting in poor control of the ill-
ess and a higher risk of morbidity and mortality. 19 , 20 Several fac-
ors identified in these studies were found to have positive and
egative associations with medication adherence. The geographic
ocation of a patient’s residence and the presence of a glucome-
er in the home were identified as positive factors in medication
dherence. 21–27 
Despite the significant influence of DM on Ethiopians, studies
ssessing DM, specifically in the area of medication adherence, in
thiopia are insufficient. A systematic review and meta-analysis of
he existing studies are required to better understand the factors
hat are associated with DM medication adherence across Ethiopia
nd to elucidate areas for further studies. 
ethods 
earch strategy 
The systematic review and meta-analysis was conducted by ad-
ering to the Preferred Reporting Items for Systematic Review and
eta-Analysis Protocols guidelines. 28 The primary literature for
his review was retrieved through electronic, Web-based searches,
ocal journals, and university thesis databases using the indexed
nd free-text terms medication adherence, therapy adherence, treat-
ent adherence, medication intake adherence, medication compliance,
atient compliance, diabetes mellitus, diabetes , Patients, individuals,
lients, and Ethiopia in various combinations, as described in Sup-
lemental Table 1 in the online version at doi: 10.1016/j.curtheres.
020.100585 . The databases Cumulative Index to Nursing and Al-
ied Health Literature, Embase, Medline, PubMed, Web of Science,
cience Direct, and Scopus were searched from May 2018 to Febru-
ry 2020. Unpublished studies were also considered from local
ournals and university thesis databases and Google scholar con-
idering the lack of Ethiopian specific studies on glucometer adher-
nce in several of the main scholarly databases. Endnote reference
anager software (version 7.1 ) was used to collect and organize
earch outcomes and to remove duplicate articles. 
nclusion criteria 
All studies that evaluated the association between DM medica-
ion adherence and the geographic location of a patient’s residence
nd presence of a glucometer in patients’ home were included.gen from ClinicalKey.com by Elsevier on August 17, 2020.
. Copyright ©2020. Elsevier Inc. All rights reserved.



















































































































t  tudies were included in the systematic review and meta-analysis
f they reported either good or poor DM medication adherence
ith a defined cutoff point and used validated measures. Studies
ith cross-sectional study design were included. Only studies writ-
en in the English language were included. Only studies conducted
n Ethiopia were included. Only studies published between 2013
nd 2019 were included. 
xclusion criteria 
Articles were excluded if they were not available in full text.
tudies were also excluded if they did not report specific outcomes
or medication adherence. 
utcome variable 
The main aim of this review was to determine the pooled
revalence of medication adherence among adult patients with di-
betes in Ethiopia. Considering the purposes of this study, “good
dherence” was determined by each individual study. Most studies
sed the Morisky Medication Adherence Scale. Descriptions of each
tudy’s measurement of good adherence are presented in Table 1 .
revalence was measured as the number of adults with above the
utoff point for good medication adherence divided by the total 
umber of adult patients with diabetes in a study multiplied by
00. For the analysis of the secondary outcomes (factors associated
ith adherence), we extracted data on factors that had been found
o be associated with medication adherence in the literature, such
s the presence of a glucometer at home and the geographic loca-
ion of a patient’s residence. Another criterion used when selecting
ariables was the frequency of reporting DM in studies included
n the meta-analysis. In examining factors associated with med-
cation adherence, data were extracted from the primary studies
sing 2 × 2 tables, and a crude odds ratio (OR) was calculated to
etermine the association between each of the independent vari-
bles and the independent variable. 
ata extraction and quality assessment 
Data were extracted following a standard format, which in-
luded first author, year of publication, regions, study design, types
f DM and medication, and sample size. The prevalence of medi-
ation adherence was also extracted from each included study. Full
exts of potentially eligible studies were assessed using the inclu-
ion criteria described previously. The relevance of the reviewed
tudies was checked based on the topic, objectives, and methodol-
gy. When it was unclear from an abstract whether or not a study
as relevant, it was excluded from full-text retrieval. A prelimi-
ary assessment was performed, and some articles were excluded
rom the first step based on the topic. After reviewing the full arti-
le, a score was given based on the Newcastle–Ottawa Scale. 29 We
lso evaluated the risk of bias in the studies that were selected
sing the 10-item rating scale developed by Hoy et al 30 for preva-
ence studies (see Supplemental Table 2 in the online version at
oi. 10.1016/j.curtheres.2020.100585 ). 
Articles were assessed for quality, with only high-quality stud-
es included in the analysis. Two authors (GD and FW) indepen-
ently assessed the quality of each article. The reviewers com-
ared their quality appraisal scores and collaborated before cal-
ulating the final appraisal score. Disagreements were settled by
 third reviewer (AN), whenever appropriate. The studies met the
ewcastle–Ottawa Scale criteria in terms of adequate sample size,
larity of research aims, and appropriateness of design, recruit-
ent, data collection, analysis, and reporting of findings. 29 Downloaded for Anonymous User (n/a) at University of Groningen
For personal use only. No other uses without permission. Coata analysis 
Data were extracted from each study using Microsoft Excel
Redmond, Washington) and were subsequently transferred to 
tata software version 14 (StataCorp, College Station, Texas) for
nalysis. Heterogeneity was checked using the Cochran Q and the
 
2 test statistic. 31 Funnel plot asymmetry and Egger test of the in-
ercept were used to check publication bias. 32 If the results of the
est suggested the presence of a significant publication bias with
 < 0.05 in Egger test and Begg test, trim and fill analysis was
sed. 33–35 To confirm the results, 2 researchers independently per-
ormed the statistical analysis to check for consistency. The effect
ize estimates were reported in the form of pooled prevalence and
Rs. 
esults 
xplanation of original studies 
The results of the search strategy yielded a total of 1046
nique citations found in Cochrane Library, EBSCO, Embase, Google
cholar, Web of Science, PubMed, Science Direct, Scopus, Hinari,
nd local journals and university thesis databases. 36 A total of 1041
rticles were excluded at initial assessment as their title was not
elated to the study scope. For the remaining 36 studies, their ab-
tract and full text was accessed. Ten articles were excluded based
n their lack of clarity in terms of the outcome variable. The re-
aining 26 studies 37–60 met the inclusion criteria and were in-
luded in the final analysis ( Figure 1 ). 
haracteristics of the included studies 
Twenty-six studies representing 7756 patients with diabetes 
ere included in the final analysis. From the included stud-
es, eight observational studies (27%) were conducted in Oro-
ia region, 38 , 47 , 48 , 52 , 53 , 55 8 articles (30.8%) were from Addis
baba, 39 , 41 , 43 , 45 , 46 , 49 , 50 5 articles (19.2%) were from Amhara re-
ion, 40 , 44 , 54 , 56 , 60 and 2 articles were from the Southern Nations,
ationalities, and People’s Region 51 , 59 and Tigray regions. 37 , 57 The
emaining 1 article was from Harari region. 42 All of the studies
ere cross-sectional in nature. Levels of good medication adher-
nce were reported as high as in Addis Ababa 41 and low as in Oro-
ia region 52 ( Table 1 ). Regarding risk bias, all studies has low risk
ias score. 
ooled estimate of reported good diabetes medication adherence 
A DerSimonian and Laird random effects model was fitted
o determine the pooled effect size 61 , 62 because the I 2 test for
eterogeneity showed a significant difference between studies 
 I 2 = 94.1%; P < 0.05). Even after a subgroup analysis was per-
ormed, the results continued to show the presence of heterogene-
ty across the studies. Therefore, we performed a meta-regression
nalysis on publication years and sample size. However, these vari-
bles were insignificantly associated with heterogeneity in these
odels ( Table 2 ). 
The average pooled estimate of reported good medication ad-
erence among patients with diabetes in Ethiopia was found to be
8.59 (95% CI, 62.00–75.18). A subgroup analysis also showed that
he pooled estimate of reported good medication adherence among
atients in Ethiopia’s regional states was 67.81% (95% CI, 59.96–
5.65), while in Addis Ababa, it was 70.37% (95% CI, 57.5–83.23)
 Figure 2 ). 
Funnel plot of precision asymmetry and Egger test of the inter-
ept were used to detect publication bias. On visual examination,
he funnel plot was found to be asymmetric, and Egger test of the from ClinicalKey.com by Elsevier on August 17, 2020.






















































Characteristics of the included studies for meta-analysis (2013–2018, Ethiopia). 
Study No. Author name Year of 
publication 
Type of DM Region Type(s) of medication Study design Sample 
size 
How good adherence was 
measured 




1 Teklay, et al 53 2013 Type 2 Oromia Oral hypoglycemic agent and 
insulin 
Cross-sectional 267 MMAS 75.7 6 
2 Gelaw, et al 47 2014 Type 1, 2 Oromia Oral hypoglycemic agent and 
insulin 
Cross-sectional 270 4-point adherence survey 72.2 6.5 
3 Gelaw, et al 48 2014 Type 1, 2 Oromia Oral and insulin Cross-sectional 275 4-point adherence survey 78.2 7 
4 Abebe, et al 44 2015 Type 1, 2 Amhara Oral hypoglycemic agent and 
insulin 
Cross-sectional 407 MMAS 45.9 7 
5 Mamo, et al 50 2016 Type 1, 2 Addis Ababa Oral hypoglycemic agent and 
insulin 
Cross-sectional 660 Adherence survey 91.7 6.5 
6 Kassahun, et al 23 , 38 2016 Type 1, 2 Oromia Oral hypoglycemic agent and 
insulin 
Cross-sectional 285 Self-reported 
non-adherence survey 
68.8 7 
7 Girma Bizu, et al 39 , 46 2016 Type 2 Addis Ababa Oral hypoglycemic agent Cross-sectional 155 MMAS 49 7 
8 Abebaw, et al 40 2016 Type 2 Amhara Oral hypoglycemic agent and 
insulin 
Cross-sectional 288 5-point MMAS 85.1 7 
9 Sorato, et al 51 2016 Type 2 SNNP Oral hypoglycemic agent and 
insulin 
Cross-sectional 194 8-point MMAS 84 7 
10 Tsehay, et al 39 2016 Type 2 Addis Ababa Oral hypoglycemic agent and 
insulin 
Cross-sectional 322 4-point MMAS 66.8 7 
11 Jemal, et al 42 2017 Type 2 Harar Oral hypoglycemic agent and 
insulin 
Cross-sectional 200 4-point MMAS 70.4 7 
12 Ali, et al 45 2017 Type 1, 2 Addis Ababa Oral hypoglycemic agent and 
insulin 
Cross-sectional 146 8-point MMAS 54.8 6 
13 Tadele, et al 52 2017 Type 1 Oromia Insulin Cross-sectional 256 Self-reported adherence 
survey 
30.9 7 
14 Mesfin, et al 43 2017 Type 2 Addis Ababa Oral hypoglycemic agent and 
insulin 
Cross-sectional 275 MMAS 51.3 6.5 
15 Gerada, et al 49 2017 Type 1, 2 Addis Ababa Insulin Cross-sectional 378 Non-adherence described 




16 Berhe, et al 37 2017 Type 2 Tigray Oral hypoglycemic agent and 
insulin 








18 Wabe, et al 55 2018 Type 2 Oromia Oral hypoglycemic agent and 
insulin 
Cross-sectional 384 Adequate glycemic 
control was defined as 
patients with fasting 
plasma glucose level 
between 90 mg/dL and 
100 mg/dL 
61.9 6.5 
19 Bonger, et al 41 2018 Type 2 Addis Ababa Oral hypoglycemic agent and 
insulin 
Cross-sectional 422 Self-reported adherence 
survey 
95.7 6 
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Table 1 ( continued ) 
Study No. Author name Year of 
publication 
Type of DM Region Type(s) of medication Study design Sample 
size 
How good adherence was 
measured 




20 Abate TW 60 2019 Type 1, 2 Amhara Insulin Cross-sectional 416 MMAS 7 68.8 6 
21 Ayele AA, et al 56 2019 Type 2 Amhara Insulin Cross-sectional 275 Adherence = taking > 50% 
of prescribed 
treatment during past 
3 d 
70.5 7 
22 Wabe NT, et al 55 2011 Type 2 Oromia Oral hypoglycemic agent and 
insulin 
Cross-sectional 384 MMAS 7 41.8 6.5 
23 Gelaw, BK et al 47 2014 Type 2 Oromia Oral hypoglycemic agent and 
insulin 
Cross-sectional 113 Self-reported adherence 
survey 
72 6 
24 Yohannes Tekalegn, et 
al 58 
2017 Type 2 Addis Ababa Oral hypoglycemic agent and 
insulin 
Cross-sectional 412 SDSCA 87.6 6 
25 Fseha B, et al 57 2017 Type 2 Tigray Oral hypoglycemic agent and 
insulin 
Cross-sectional 200 Adherence = taking > 50% 
of prescribed 
treatment during past 
3 d 
61 6 
26 Tesfaye DK, et al 59 2015 Type 1, 2 SNNP Oral hypoglycemic agent and 
insulin 
Cross-sectional 247 SDSCA 91.9 6.5 
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Figure 1. Flow diagram showing the procedure of selecting studies for meta-analysis in Ethiopia 2013–2019. 




















f  ntercept (B0) was found to be –0.22 (95% CI, –0.31 to -–0.13; P <
.05). Furthermore, publication bias was also indicated using the
egg test with a P value < 0.05. Hence, the final effect size was
etermined by performing trim and fill analysis using the random
ffects model. However, relatively different results were obtained
sing the model. 
ssociation between reported good medication adherence and the 
resence of a glucometer 
Three studies 37–39 were included in the analysis assessing the
ssociation between the presence of a glucometer and reportedDownloaded for Anonymous User (n/a) at University of Gronin
For personal use only. No other uses without permissionedication adherence ( Figure 3 ). A statistically significant associ-
tion was observed between a good level of reported medication
dherence and the presence of a glucometer in the home of pa-
ients with diabetes. The pooled effect size OR of reported good
edication adherence among patients with diabetes who have glu-
ometer at home was 2.12 (95% CI, 1.42–3.16). 
ssociation between reported good medication adherence and 
eographic location of a patient’s residence 
Four studies were included in this subanalysis assessing the ef-
ect of the geographic location of a patient’s residence on reportedgen from ClinicalKey.com by Elsevier on August 17, 2020.
. Copyright ©2020. Elsevier Inc. All rights reserved.
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Figure 3. Forest plot showing the association between good diabetic medication adherence and the presence of a glucometer among diabetic patients in Ethiopia from 2013 
to 2019. 
Table 2 
Meta-regression results on selected variables in studies conducted from 2013 to 
2019 in Ethiopia. 
Variable Coefficient P value 
Publication year –3.5 0.762 
Sample size 0.052 0.712 
Region 
Addis Ababa –23.1 0.795 
Amhara –27.43 0.766 
Harar –13.3 0.905 
Oromia –33.5 0.705 
SNNP 0.3 0.998 
































































edication adherence ( Figure 4 ). A statistically significant associ-
tion was not observed between the geographic location of a pa-
ient’s residence and a good level of reported medication adher-
nce (OR = 1.81; 95% CI, 0.78–4.21). 
iscussion 
The systematic review and meta-analysis were conducted to
stimate the proportion of reported good medication adherence
mong DM patients in Ethiopia and its associated factors. Dur-
ng a time of epidemiological transition in Ethiopia, when obesity
revalence and rates of noncommunicable diseases are increasing,
t is important to better understand the influence that DM has on
thiopians and how Ethiopians are managing their disease. 
We found that, on average, more than two-thirds (68.59%) of
atients with diabetes in Ethiopia had good reported medication
dherence. Regardless of the region in which they lived, levels of
eported good adherence improved when patients had access to
 glucometer in their home to self-check their glucose levels. Our
revalence of reported good DM medication adherence is almost
dentical to that found in a previous systematic review and meta-
nalysis conducted by Iglay et al 63 at the global level, which found
hat 67.9% of patients were considered adherent to their DM med-
cation. These results were also consistent with the results of Ode-
ard and Capoccia 66 and studies published by Cramer et al. 64 Downloaded for Anonymous User (n/a) at University of Groningen
For personal use only. No other uses without permission. CoEthiopians face universal challenges in adherence and also chal-
enges that are unique to Ethiopia when trying to adhere to their
M medication. Similar medication adherence levels in Ethiopia
nd high-income countries may be due in part to the similarities
n the difficulty of maintaining medication adherence with chronic
iseases. For example, challenges such as forgetfulness have been
bserved across several countries with a wide range of health
are resources. 65 Other common challenges such as cost of med-
cation, accessibility of health care facilities, lack of patient edu-
ation, and poor patient-provider relationships may be more se-
ere in Ethiopia compared with the other countries. 26 Consider-
ng these challenges, it is heartening that Ethiopia is able to main-
ain a similar medication adherence level as that of higher-income
ountries. 
Subgroup analysis performed on regions in which patients lived
ound no significant difference in reported adherence by region.
his consistency could be explained by Ethiopia’s centralized na-
ional health system, which standardizes health education and ser-
ices. Although there might have been differences in the accessi-
ility of health care and health care providers by region, the pa-
ients with diabetes in the included studies probably had similar
evels of short-term health education based on the national medi-
ation adherence guidelines. Whether a patient lives in the capital
r outside of the capital, in a predominantly rural or urban region,
he type of health education would be fairly consistent. 
An additional aim of this study was to determine associated
actors for good antidiabetic medication adherence. We found that
here was a significant association between the presence of a glu-
ometer and reported good medication adherence. DM patients
ho measured their own blood glucose level using a glucome-
er at home were more than three times more likely to have had
ood level of reported medication adherence compared with pa-
ients who did not measure their own blood glucose levels using
 glucometer at home. This is probably because the presence of a
lucometer allows patients to measure blood glucose on a regular
asis and to prevent hyperglycemia or hypoglycemia. However, it
ay also be the result of the presence of confounding factors with
ncome or education as higher-income and more educated patients
ay be more likely to both have glucometers and also more likely
o be adherent.  from ClinicalKey.com by Elsevier on August 17, 2020.
pyright ©2020. Elsevier Inc. All rights reserved.
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Figure 4. Forest plot showing the association between a good level of diabetic medication adherence and geographic location of a diabetic patient’s residence in Ethiopia 



































































Although both our study and the previous global meta-
nalysis 66 found that more than two-thirds of the study population
aintain a good level of DM medication adherence, it must be em-
hasized that almost one-third of these study populations had low
evel of DM medication adherence. Patients who do not adhere to
M medication regimens are at a higher risk for later disease com-
lications and higher costs to health care systems and patients per-
onally than patients who adhere to DM medication regimes. Our
ndings indicate that medication adherence among DM patients is
 significant issue in Ethiopia and suggest that the disease could be
aid careful attention to by global and local authorities. We hope
hat in addition to highlighting this potential oversight and empha-
izing the need to strengthen glucometer availability program, our
ndings could also be used as a reference or baseline for Ethiopian
olicy makers in creating guidelines for future levels of good med-
cation adherence. 
imitations 
The findings of this review need to be considered in the con-
ext of several important limitations. The protocol is not registered.
ore importantly, there was a lack of uniformity in defining good
edication adherence across the studies included in the review. It
as, therefore, defined on a study-by-study basis, which may bias
he results of our meta-analysis. Additionally, due to the absence
f data, crude ORs were used to estimate factors associated with
he outcome variable; this means that we were not able to control
he potential confounding factors. 
onclusions 
A significant proportion of adult patients with diabetes in
thiopia had good reported medication adherence. Reported med-
cation adherence was improved with the presence of a glucome-
er in the patient’s home. The geographic location of a patient’s
esidence was not found to be associated with DM reported med-
cation adherence. Because of the potential reduction in morbidity
nd mortality of DM due to the presence of a glucometer, future
tudies should continue to investigate this association and other
otential interventions to increase DM medication adherence. Downloaded for Anonymous User (n/a) at University of Gronin
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